PFE logo

PFE
Pfizer Inc

106,029
Mkt Cap
$152.39B
Volume
56.02M
52W High
$28.75
52W Low
$21.97
PE Ratio
19.77
PFE Fundamentals
Price
$26.48
Prev Close
$26.79
Open
$27.53
50D MA
$27.20
Beta
0.40
Avg. Volume
41.88M
EPS (Annual)
$1.36
P/B
1.76
Rev/Employee
$834,386.67
$196,372.70
Loading...
Loading...
News
all
press releases
Promising Medical Stocks To Follow Today - April 28th
UnitedHealth Group, Arcellx, Eli Lilly and Company, Pfizer, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares...
MarketBeat·1h ago
News Placeholder
More News
News Placeholder
Best Pharmaceutical Stocks To Keep An Eye On - April 28th
Eli Lilly and Company, Pfizer, BridgeBio Pharma, AbbVie, Novo Nordisk A/S, Abbott Laboratories, and Ascendis Pharma A/S are the seven Pharmaceutical stocks to watch today, according to MarketBeat's...
MarketBeat·1h ago
News Placeholder
BBIO On Track For Worst Day In 2.5 Months: What’s The Pfizer Connection?
BridgeBio is a primary competitor to Pfizer in the Transthyretin Amyloid Cardiomyopathy (ATTR-CM) market.
Stocktwits·3h ago
News Placeholder
Amneal 2026-2027 Upside From Biosimilars Scale
AMRX targets 2027 upside through biosimilars scale, new complex launches, and Specialty recovery after 2026 Rytary erosion pressure.
Zacks·4h ago
News Placeholder
Should You Buy, Sell, or Hold Pfizer at $27?
Key PointsPfizer's growth rate has tanked in recent years, and investors remain concerned about the future...
Nasdaq News: Markets·4h ago
News Placeholder
Pfizer Reaches Three Settlement Agreements for VYNDAMAX
Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in...
Business Wire·6h ago
News Placeholder
Earnings Preview: Pfizer (PFE) Q1 Earnings Expected to Decline
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7h ago
News Placeholder
Pfizer (PFE) Projected to Post Earnings on Tuesday
Pfizer (NYSE:PFE) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-pfizer-inc-stock...
MarketBeat·8h ago
News Placeholder
Relay Therapeutics Unveils Zovegalisib Triplet Data, Signs Pfizer Supply Deal for Phase III Plan
Relay Therapeutics (NASDAQ:RLAY) outlined new data and development plans for its lead oncology program, zovegalisib, during a frontline breast cancer update conference call, highlighting encouraging...
MarketBeat·15h ago
News Placeholder
Pharmaceutical Stocks To Watch Today - April 27th
Organon & Co., Eli Lilly and Company, Abbott Laboratories, AbbVie, Novo Nordisk A/S, Pfizer, and Gilead Sciences are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock...
MarketBeat·24h ago
<
1
2
...
>

Latest PFE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.